It is linked to elevated levels of fibrinogen and C-reactive protein, diabetes, insulin resistance, dyslipidemia, and hypertension, all of which raise the risk of CVD events ( It is less evident how GLP-1 agonists directly affect arrhythmias, some studies suggest they may reduce frequency of arrythmias because their favorable effects on metabolism and over all cardiovascular health
Zbucki, R
For example, the aflibercept (Eylea, Regeneron) HCPCS description is: J0178 injection, aflibercept, 1 mg
An underdosed vial makes every calculation above meaningless, no matter how precise your math is
Moreover, the gut-selective dose of sitagliptin was unable to lower TG excursion in HFD-fed Dpp4 EC+/+ and Dpp4 EC/ mice, before and after BMT, despite an approximately 20% reduction in plasma DPP-4 activity and an increase in active GLP-1 (Figure 7)
Weight: Weigh yourself daily at the same time (ideally morning, after using the bathroom, before eating)